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Abstract
Background Hydatid disease of the liver remains ende-
mic in the world and is an imported disease in The Neth-
erlands. The aim of this study was to evaluate the treatment
and outcome of surgically treated patients for hydatid
disease in a single center in The Netherlands.
Methods This retrospective study included 112 consecu-
tive patients surgically treated for hydatid disease between
1981 and 2007. The primary outcome was relapse of the
disease. Secondary outcomes were infections, complica-
tions, reoperations, length of hospital stay, and mortality.
Results In all cases, echinococcosis was diagnosed by
computed tomography or ultrasonography (US). Serology
(enzyme-linked immunosorbent assay, immunoﬂuores-
cence) conﬁrmed the diagnosis in 92.9%. Most of the cysts
were seen only in the liver (73.5%). All cysts were oper-
ated on with the frozen seal technique. Relapse of disease
was seen in 9 (8.0%) cases. Five (4.5%) required surgical
treatment at a later stage. Twenty (17.9%) complications
were recorded. Four (3.6%) needed radiological drainage
and three (2.7%) a reoperation. Follow-up was performed
with US and/or serology at a mean of 24 months (range
0.5–300 months). All but one complication were seen in
the liver-operated group, this proved not to be of statistical
signiﬁcance (P = 0.477). Patients with complications
stayed signiﬁcantly longer in hospital than did the patients
without complications (P\0.001). No mortality was
observed in this study.
Conclusions The present study suggests that the frozen
seal method of surgery for hydatid disease is safe and
effective. Future studies are needed to prove its position in
the treatment of hydatid disease as new developments show
promising results.
Introduction
Hydatid cyst disease, or human cystic echinococcosis, is a
zoonotic infection mainly caused by the larval forms of the
tapeworm Echinococcus granulosus [1–8]. Echinococcosis
occurs worldwide in endemic large sheep-raising areas
including Africa, the Mediterranean region of Europe, the
Middle East, Asia, South America, Australia, and New
Zealand [2, 3, 5–10]. The incidence of hydatid disease in
Western industrial nations is relatively low [6, 8, 10, 11].
However, the prevalence of the disease has increased in
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eling [5, 12]. In The Netherlands it is almost always an
imported disease [13, 14]. The most frequent site for cystic
lesions is the liver (60% of cases) followed by the lungs
(about 20% of cases). In fact, infection can affect all tissues
in the human body [1, 3, 6–8, 10, 11, 15].
There are three treatment options for hepatic cystic
echinococcosis: chemotherapy, surgery, and percutaneous
drainage (puncture, aspiration, injection, reaspiration—also
known as PAIR) or a combination of these therapies [6–8].
Although PAIR has been investigated by several groups,
there is still no consensus about the best treatment. Surgery
may vary from conservative (cystectomy) to radical
(complete open resection) to laparoscopic techniques. The
debate on the best surgical approach is still ongoing,
whether it is conservative surgery or radical surgery in
which the cyst is totally removed including the pericyst by
total pericystectomy or partial hepatectomy [16].
In an area where hydatid disease is not endemic and
therefore not a routine treatment, it is of major importance
to perform a safe, reproducible technique with a low
complication rate. The frozen seal method as surgical
treatment for hydatid disease, described by Saidi and
Nazarian during the 1970s, has been used in the Harbour
Hospital since 1981 [17]. The aim of this study was to
investigate the results of the frozen seal method as treat-
ment of echinococcosis in a specialized center in The
Netherlands over the past 25 years.
Methods
This study included all consecutive surgically treated
patients in the Harbour Hospital in Rotterdam, The Neth-
erlands, between 1981 and 2007. All medical records were
reviewed concerning the following parameters: age, sex,
country of origin, presentation of symptoms, location and
type of cysts diagnosed by radiologic imaging, treatment,
hospital stay, and outcomes. Radiologic workup included
conventional radiology, ultrasonography (US), and com-
puted tomography (CT). Laboratory tests and serology
were performed to conﬁrm the diagnosis. Enzyme-linked
immunosorbent assay (ELISA), immunoelectrophoresis
(IE), and in most cases the complement binding reaction
(CBR) were used as serologic testing for diagnosis and
follow-up.
Primary outcome was relapse of disease. Secondary
outcomes were infections, complications, spilling of
hydatid cyst content, reoperations, length of stay, and
mortality.
An echinococcal cyst was diagnosed if any two of the
features were present: (1) typical sonographic and CT
appearance demonstrating a multilocular cystic lesion with
daughter cysts, calciﬁcation of the cysts walls, or both; (2)
positive indirect hemagglutination test or ELISA for echi-
nococcal infection; and (3) histology demonstrating a
parasite-derived laminated membrane with or without
viable scolices [4, 11, 18]. Indications for surgery were the
presence of pain, jaundice, fever, dyspnea, or cardiac
decompensation. The World Health Organization (WHO)
indications for surgery were respected in all cases: large
liver cysts with multiple daughter cysts, infected cysts, and
cysts communicating with the biliary tree. Moreover, sur-
gery was considered indicated in the presence of cysts in
the lung, heart, and other organs [11, 15].
Prior to the operation in some cases (n = 28, 25.0%)
albendazole (400 mg twice a day) was administered and
continued 3 months after surgery. Before 1988, mebenda-
zole was used in selected cases (n = 19, 17.0%). From
1990, albendazole was given depending on the patient’s
clinical situation (severe pain, fever, other clinical signs of
echinococcosis infection). From 1995, the regimen was
standardized, and almost all patients received preoperative
drug treatment (14/15 patients), One patient received
Eskazole (albendazole).
Surgical technique
In this study, the frozen seal technique was used for open
surgery in all cases. For hydatid cysts in the lung or
myocardium, the thorax was opened via a median ster-
notomy incision. For liver cysts, the abdomen was exposed
through a bilateral subcostal incision, abdominal viscera
were examined for potential sites of dissemination, and the
liver was mobilized. Using this technique, a 7 cm long
metal cone with a large (8 cm diameter) upper and 4 cm
lower aperture was used. It has ﬁne tubing soldered to the
rim of the lower opening. A refrigerant is circulated via the
inlet of the tubing. In this setting, Freon was used in all
cases as refrigerant. The ring-shaped tubing of the cone
was frozen onto the cyst on the surface of the liver (or
lung), producing a watertight frozen seal. The contents of
the cysts could then be evacuated through the cone without
risk of uncontrolled rupture or spilling [13, 17, 19]. Nor-
mally, the ﬂuid is crystal clear. If the ﬂuid was turbid, a
communication with bile ducts or secondary infection was
suspected, and material for bacteriologic examination was
obtained (and, consequently, antibiotic treatment was
started).
Then the membrane was excised completely and the
residual space was meticulously inspected for biliary
communication. If there was any suspicion of biliary
communication, ﬁstulas were closed with absorbable
sutures. If no communication was present, the residual
cavity was ﬂushed for 2 min with a freshly prepared 0.5%
silver nitrate solution to kill any remaining scolices. The
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provided by Saidi and Nazarian [17, 20]. Silver nitrate
0.5% solution proved to be a suitable alternative for for-
malin in a mouse model with standardized intraperitoneal
inoculation techniques. It effectively sterilized scolices
within 2 min and, more importantly, was completely non-
toxic to other tissues. Clinical application of silver nitrate
0.5% led to effective treatment without any local or sys-
temic effect of the silver nitrate washout in more than 55
surgically treated patients with liver and lung hydatid cysts
[20].
After the use of silver nitrate solution, crypts or recesses
were carefully checked for residual cyst material. If pres-
ent, it was removed, and a second treatment with silver
nitrate solution was administered.
Again, the residual cavity was meticulously inspected
for biliary communication. Any visible ﬁstulas were
sutured with absorbable sutures. If the residual space
communicated with bile ducts or bronchus, any contact
between the silver nitrate solution and these structures was
avoided either by compressing the liver or increasing the
end-expiratory pressure of lung ventilation. No residual
space should be present after this procedure as it probably
enhances the possibility of infection. Therefore, the cavity
was ﬁlled with hypertonic saline and closed with nonab-
sorbable sutures or, in selected cases, obliteration with
greater omentum was performed.
If appropriate, cavities were drained with 18F vacuum
tubes, and an additional subhepatic drain was placed in
selected cases to control any possible biliary leakage.
Drains were removed on the ﬁfth to seventh postoperative
day. Patients who required prolonged drainage were con-
sidered to have biliary ﬁstulas. For patients with symptoms
of an obstructed or communicating common bile duct
(CBD), intraoperative cholangiography and choledochot-
omy with T-tube drainage were performed. In selected
cases, endoscopic retrograde cholangiopancreatography
(ERCP) was performed to drain the CBD.
Follow-up
Complications were deﬁned as ‘‘every unwanted develop-
ment in the illness of the patient or in the treatment of the
patient’s illness that occurs in the clinic’’ [21]. Complica-
tions were classiﬁed according to the recent grading system
of Dindo et al. (Table 1)[ 22]. Spilling was considered an
error in technique that could lead to a complication
(infection) or relapse of disease.
After discharge, all patients were followed periodically
at the ﬁrst, third, sixth, and twelfth postoperative month
during the ﬁrst year and at least once a year thereafter.
Seamen were unable to be followed long term. The follow-
up procedure included physical examination, serologic
tests, US of the abdomen, and CT scanning in particular
cases. Relapse or recurrence of disease was deﬁned as the
appearance of new extrahepatic disease resulting from
procedure-related spilling or reappearance of live cysts at
the site of a previously treated cyst [7, 23].
Table 1 Classiﬁcation of surgical complications
Grade
1 Deﬁnition
I Any deviation from the normal postoperative course without the need for pharmacologic treatment or surgical, endoscopic, and
radiologic interventions
Allowed therapeutic regimens are drugs as antiemetics, antipyretics, analgesics, diuretics, electrolytes, and physiotherapy. This grade
also includes wound infections opened at the bedside
II Requiring pharmacologic treatment with drugs other than such allowed for grade I complications
Blood transfusions and total parenteral nutrition are also included
III Requiring surgical, endoscopic, or radiologic intervention
IIIa Intervention not under general anesthesia
IIIb Intervention under general anesthesia
IV Life-threatening complication (including CNS complications)
2 requiring IC/ICU management
IVa Single organ dysfunction (including dialysis)
IVb Multiorgan dysfunction
V Death of a patient
From Dindo et al. [22]
CNS central nervous system, IC intermediate care, ICU intensive care unit
1 The sufﬁx ‘‘d’’ (for ‘‘disability’’) is added to the respective complication grade if the patient suffers from a complication at the time of
discharge. It indicates the need for follow-up to evaluate the complication fully
2 Brain hemorrhage, ischemic stroke, subarachnoidal bleeding but excluding transient ischemic attacks
108 World J Surg (2010) 34:106–113
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Categoric variables were presented as numbers (percent-
ages) and continuous variables by the median and range.
Complications were analyzed using Fisher’s exact test.
Hospital stay was analyzed using the Mann–Whitney
U-test. The analyses did not account for missing data. A
value of P\0.05 was considered to be statistically
signiﬁcant. Data were analyzed using SPSS version 13.0
for Windows (SPSS, Chicago, IL, USA).
Results
The study describes a total of 112 consecutive patients who
underwent surgery for hydatid disease during the years
1981–2007 at Harbour Hospital, Rotterdam, The Nether-
lands. All but ﬁve patients were from abroad, either
immigrants or seamen. Demographic data are presented in
Table 2. At clinical presentation, the complaints consisted
mainly of abdominal pain [n = 87 (77.7%)], abdominal
mass [n = 43 (38.4%)], fever [n = 20 (17.9%)], and urti-
caria [n = 11 (9.8%)] or a combination of these symptoms.
Also, acute abdominal complaints due to rupture [n = 3
(2.7%)], cardiac decompensation [n = 2 (1.8%)], anaphy-
laxis [n = 1 (0.9%)] and jaundice [n = 8 (7.1%)] were
seen at presentation. In all cases, echinococcosis was
diagnosed by US and CT scanning. Serology [ELISA,
immunoﬂuorescence (IMF)] conﬁrmed the diagnosis in
92.9% of the cases. Liver function tests were abnormal
only when the hepatic ducts were involved.
Most of the cysts were seen only in the liver, although
other, more rare locations were found including the myo-
cardium and the adductores muscles in the right leg. The
locations are given in Table 3 together with the number of
complications per organ. Surgery was performed in all
cases [n = 112] with the frozen seal method, and more
than 196 cysts were operated on in the liver, lungs, and
abdomen. Primary and secondary outcomes were scored in
the clinic and after discharge during a median follow-up of
24 months (0.5–300 months) (Table 4). Twelve patients
(10.7%) were lost to follow-up. Relapse of disease was
observed in nine patients (8.0%) during a median follow-up
period of 33 months (10–300 months). In this group with
recurrence (n = 9), 6 patients were initially treated before
and after surgery with medication (mebendazole n = 2,
abendazole n = 4, no medication n = 3). Regarding fur-
ther treatment, four patients (3.6%) needed ﬁve reopera-
tions (4.5%) at a later stage. The remaining ﬁve patients
were treated successfully with albendazole (400 mg twice
a day).
Grade I complications (n = 2) consisted of two wound
infections. The moderate complications (grade II, n = 10)
were two biliary ﬁstulas, two pneumonias, two urinary tract
infections, and four infections of the remnant cavity. More
severe complications (grade III) with interventions con-
sisted of fascia dehiscence, pleural effusion, and cavity
infections and/or abscesses that required radiological
drainage (n = 4) or relaparotomy (n = 3). One grade IV
complication, acute respiratory distress syndrome (ARDS),
occurred after percutaneous treatment of a hydatid cyst in
the liver in segment 8 due to perforation and rupture to the
lung. No complications or abnormal liver function tests
were noted related to the use of silver nitrate 0.5% solution.
No mortality was observed in this study.
All but one of the complications were observed in the
liver-operated group, which proved not to be of statistical
signiﬁcance (P = 0.477). Even after dividing the hydatid
locations in only two groups—liver (19/99 patients, or
19.2% complication rate) and other organs (1/13, or 7.7%
complication rate)—no signiﬁcant difference was found
(P = 0.457). Also, no signiﬁcant difference was seen when
the grading of complications was analyzed (P = 0.881).
However, if a complication occurred, these patients stayed
signiﬁcantly longer in hospital than the patients without
complications (P\0.001). The median stay was 20.5 days
(10–156 days) in the group with complications (n = 20)
versus 12 days (2–52 days) in those without complications
(n = 87).
Of the 112 consecutive patients, 3 were treated with a
percutaneous technique prior to surgical treatment. This
was decided in a multidisciplinary meeting prior to the
intervention, and it was considered suitable for treatment.
The ﬁrst patient needed a thoracoabdominal exploration
Table 2 Demographic data from patients treated for hydatid disease
in the Harbour Hospital: 1981–2007
Age (median, range) 38 (7–70) years
Sex (M:F) 52:60
No. of patients, by country of origin
Armenia 1
India 1
Italy 2
Iraq 1
Lebanon 1
Libya 1
Morocco 37
The Netherlands 5
Spain 3
Sudan 1
Turkey 52
Uruguay 1
Unknown 4
Yugoslavia 2
Total 112
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123because biliary pleuritis persisted after PAIR and required
surgical treatment. Another patient was treated by PAIR for
a hydatid cyst in the liver and was operated on with the
frozen seal technique for the spleen without complication.
The third patient was the previously described patient with
ARDS (grade IVd complication).
Spilling of cyst content was reported in four cases,
without complications or recurrence in these patients dur-
ing follow-up of 22.5 months (range 5–39 months). Two
ERCPs were performed prior to the liver operation. An
ERCP was done in the ﬁrst patient to analyze the cause of
the abnormal liver function tests. This patient was admitted
in 1981 to the Department of Internal Medicine. After CT
scanning, he was referred to the Department of Surgery to
be treated surgically. The second ERCP was performed
2 years later in a patient to analyze the cause of persistent
high bilirubin levels in the serum. The sonography showed
an enlarged biliary tree and a cystic process in the right
liver lobe. A parasitic infection was suspected at ﬁrst, but
serology was negative for echinococcosis. ERCP showed a
stone in the common bile duct (CBD). Four days later,
cholecystectomy with CBD exploration was planned.
However, the ‘‘stone’’ seen by ERCP proved to be a large
daughter cyst and was removed. The large hydatid cyst in
the liver was also treated, and T-tube drainage was per-
formed. Postoperative medical treatment with mebendazole
was started, and the patient was discharged in good
condition 1 month later.
Discussion
The present study showed that the use of a previously
described frozen seal technique is safe and effective for the
surgical treatment of hydatid disease in a nonendemic area.
No mortality was seen in more than 25 years of surgically
treated echinococcosis, and the recurrence rate and mor-
bidity were low. In fact, the results can be compared
favourably to the recent meta-analysis where the clinical
outcomes of 769 patients with hepatic echinococcosis
Table 4 Primary and secondary outcomes of all 112 consecutive
patients surgically treated for hydatid disease in the Harbour Hospital:
1981–2007
Primary outcome
Relapse of disease 9 (8.0%)
Intervention (reoperation) 5 (4.5%)
Secondary outcome
Complications
Grade I 2 (1.8%)
Grade II 10 (8.9%)
Grade IIIa 4 (3.6%)
Grade IIIb 3 (2.7%)
Grade IV(d) 1 (0.9%)
Grade V (death) 0
Reoperation 3 (2.7%)
Length of hospital stay (mean, range) 14 (2–156) days
Results are the number and percent of patients unless otherwise
indicated
Table 3 Number, location, and
largest diameter of hydatid cysts
from patients surgically treated
in the Harbour Hospital: 1981–
2007
In some records the diameter
and/or the numbers of cysts
were not reported but were
regarded as multiple. These are
not reported in this table*
Organ No. of cysts Complications
(no. of patients)
Liver* (no. of patients) 144 (73.5%) 19 (95.0%)
Grade I (n = 2)
Grade II (n = 10)
Grade IIIa (n = 3
Grade IIIb (n = 3)
Grade IV (n = 1)
Lung* 26 (13.3%)
Myocardium* (grade IIIa) (n = 1 patient) 5 (2.6%) 1 (5.0%)
Spleen 4 (2.0%)
Bladder 3 (1.5%)
Other
m. psoas 6 (3.1%)
m. adductores 1 (0.5%)
Mesocolon 2 (1.0%)
Retroperitoneum 2 (1.0%)
Skin 3 (1.5%)
Total patients 196 20
Diameter (cm), mean and range 8.6 (2–28)
110 World J Surg (2010) 34:106–113
123treated with the PAIR technique were compared with 952
era-matched historical controls undergoing surgical inter-
vention [8]. In this meta-analysis of 14 studies on surgical
treatment in endemic areas, minor and major complication
rates of 33.0% and 25.1%, respectively, were reported. The
mortality rate was 0.7% (n = 7) among the surgically
treated patients. In a more recent single-center study of this
matter with 171 patients, a mortality rate of 1% was
reported for 10 years of open surgical treatment [7]. For
this group of open surgery, the investigators observed a
morbidity rate of 28% and a recurrence rate of 16.2%.
A drawback of the present study may be the retrospec-
tive setting, which could account for a bias for the com-
parison with reports in the literature. However, most of the
studies in the ﬁeld of surgical treatment of hydatid disease
are of the same retrospective design [2, 7, 24–31].
There are different opinions concerning the optimal
treatment for patients with hepatic echinococcal disease.
The goal of treatment of hydatid disease is to eliminate the
parasite completely and thereby prevent (or treat) compli-
cations including secondary infection, rupture of the cyst,
anaphylactic reaction, pressure on adjacent structures, and
penetration into the biliary tract. It is also important to
prevent recurrent disease as it is known that there is a
considerable rate of recurrence, possibly caused by intra-
operative spilling [5, 7, 11, 32].
In theory, there are three treatment options for hepatic
cystic echinococcosis: chemotherapy, surgery, and percu-
taneous drainage or a combination of these therapies [7, 8].
However, the use of chemotherapeutic agents alone, such
as mebendazole or albendazole, is controversial because of
their limited efﬁcacy. These antiparasitic drugs are often
administered as adjuvant therapy during surgery or percu-
taneous treatment. In selected cases, they can be the pri-
mary approach when surgery is not feasible or is unsafe [8,
10, 32].
Percutaneous drainage is another method for treating
hepatic hydatid disease. The PAIR technique consists of
several sequential steps: After percutaneous aspiration of
the hydatid cyst under US or CT guidance, a protoscoli-
cidal agent (20% sodium chloride solution or 95% ethanol)
is injected into the cyst cavity; the ﬁnal step is reaspiration
of the cyst contents. The advantage of PAIR is that it is less
invasive [5, 32]. In the case of uncomplicated hepatic
hydatid cysts, percutaneous drainage in combination with
albendazole therapy is an effective, safe alternative to
surgery and requires a shorter hospital stay [2, 3, 7, 10, 31,
33, 34]. In this study, only three patients were treated with
PAIR, with two complicated procedures, and these patients
needed surgery thereafter.
The third method for managing cystic echinococcosis of
the liver is surgery. The surgical approach remains the
cornerstone of the treatment for hydatid disease [1, 3, 7, 10,
15, 31, 32, 35]. Some suggest that a combination of surgery
and antiparasitic agents is the preferred treatment as it is
associated with low morbidity, mortality, and recurrences
rates [10, 36]. Surgery of liver hydatid cysts is intended to
remove the parasite completely by a procedure that
includes safe, complete exposure of the cyst, safe decom-
pression of the cyst, safe evacuation of the cyst contents,
sterilization of the cyst, treatment of biliary complications,
and management of the remaining cyst cavity. Surgeons
must also try to prevent intraoperative spilling and to save
healthy issue [1, 5, 6, 11, 36].
The WHO has published a list of indications for surgical
treatment: large liver cysts with multiple daughter cysts;
single superﬁcially situated liver cysts that may rupture
spontaneously or as the result of trauma; infected cysts;
cysts communicating with the biliary tree and/or exerting
pressure on adjacent vital organsl and cysts in the lung,
brain, kidney, bones, and other organs [11, 15].
Important complications following surgery for hydatid
liver echinococcosis are recurrences, with a reported inci-
dence of 1.1% to 25.0%, which may be caused by spilling
the cyst’s contents during a previous operation [4, 25, 26,
29, 31, 32, 37]. In the present study, only four cases of
intra-perative spilling were reported (3.6%), without any
recurrence in almost 2 years of median follow-up.
Surgical interventions can be divided into conservative,
radical, and laparoscopic procedures. Conservative, tissue-
sparing techniques consist of evacuating the cyst and
leaving the pericyst in situ, whereas radical procedures
remove both the cyst and the pericyst. The most common
conservative techniques include simple tube drainage,
marsupialization, capitonnage, derooﬁng, partial cystec-
tomy, and open or closed total cystectomy with or without
omentoplasty. Conservative operations have good results
regarding blood loss and length of hospital stay [36].
Radical approaches consist of total pericystectomy or
liver resection (hemihepatectomy or lobectomy) in which
the cyst content and the entire pericystic membrane are
removed [1, 2, 4–6, 11]. Radical resection means extensive
dissection, leading to a large wound area with a possibly
increased risk of bleeding or bile leaks [2, 33, 36]. This
technique has also advantages for the treatment of hydatid
disease. It is suggested to be a safe, highly effective tech-
nique with lower mortality, morbidity, and recurrence rates
than for conservative surgery [5, 7, 35]. This can be par-
tially explained by the fact that, compared to endocystec-
tomy, excision of the cyst and pericyst minimizes the risk
that daughter cysts persist in situ [10, 36].
Recurrences are often related to spillage of the cyst
content [7, 33]. Therefore, Saidi and Nazarian [17] devel-
oped a method to prevent spillage of the cyst content. They
devised a cone, which simpliﬁes disinfection of the cyst
cavity, as used in this study [11, 13, 17, 19]. This procedure
World J Surg (2010) 34:106–113 111
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centered on the apex of the cyst. After opening the cyst
through the cone, the parasite is sucked off entirely, fol-
lowed by disinfection of the remaining cavity [11, 13, 17,
19].
The laparoscopic approach has a growing role in the
treatment of hepatic hydatid cysts [2, 7, 32, 38]. Current
data suggest that this minimally invasive surgical technique
is feasible, safe, and effective [1, 2, 7, 39–44]. Unfortu-
nately, randomized controlled trials are still lacking, which
results in continuing debate about the optimal operation
technique for hydatid disease [2, 4, 11, 16, 36]. It is of
major importance to select the appropriate therapy care-
fully, remembering the benign nature of this cystic disease
[32]. Careful patient selection is based on the size, number,
and location of the cysts, the patient’s characteristics, and
the experience of the clinician [4, 10].
Conclusions
The frozen seal method of surgery from the past century is
still safe and effective in the new millennium. It is espe-
cially useful in centers in nonendemic areas to facilitate
working with a reproducible technique and, more impor-
tantly, to obtain high efﬁcacy and low morbidity rates.
Future studies are needed to prove its position in the
treatment of hydatid disease as new developments show
promising results.
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